Cardiovascular involvement in multisystem inflammatory syndrome in children with COVID-19

Abstract

In children, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections typically result in a less severe coronavirus 19 (COVID-19) presentation than in adults. However, a subset of children presents with severe multisystem inflammation associated with recent SARS-CoV-2 infection or COVID-19 exposure in the previous weeks. The Center for Disease Control (CDC) has termed this condition a multisystem inflammatory syndrome in children (MIS-C). MIS-C causes significant cardiovascular involvement, which can be a determinant of clinical course and outcomes. A subset of MIS-C patients presents with hypotension and shock either from acute myocardial dysfunction or systemic vasodilation, with at least of third of patients developing cardiac manifestations from the illness. In addition, myocarditis, pericarditis, valvular regurgitation, coronary artery involvement, and arrhythmias have been reported, with a smaller subset of patients requiring extracorporeal membrane oxygenation. Here, we report our institutional experience of MIS-C over the last year and present a narrative review of cases reported in the literature. In addition, we discuss the clinical protocol of diagnosis and acute and follow-up management of these patients with MIS-C.

Keywords

MIS-C / COVID-19 / cardiac function / coronary artery dilation

References

[1] COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.MMWR Morb Mortal Wkly Rep2020;69:422-6

[2] Ahmed M,Moreira A.Multisystem inflammatory syndrome in children: a systematic review.EClinicalMedicine2020;26:100527 PMCID:PMC7473262

[3] Abrams JY,Oster ME.Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review.J Pediatr2020;226:45-54.e1 PMCID:PMC7403869

[4] Centers for Disease Control and Prevention. Emergency preparedness and response: multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) health advisory. Available from: https://emergency.cdc.gov/han/2020/han00432.asp. [Last accessed on 23 Sep 2021]

[5] Dufort EM,Chow EJ.New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation TeamMultisystem inflammatory syndrome in children in New York State.N Engl J Med2020;383:347-58 PMCID:PMC7346766

[6] Sperotto F,Son MBF,Newburger JW.Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.Eur J Pediatr2021;180:307-22 PMCID:PMC7429125

[7] Sanil Y,Safa R.Echocardiographic indicators associated with adverse clinical course and cardiac sequelae in multisystem inflammatory syndrome in children with coronavirus disease 2019.J Am Soc Echocardiogr2021;34:862-76 PMCID:PMC8089028

[8] Radia T,Agrawal P.Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation.Paediatr Respir Rev2021;38:51-7 PMCID:PMC7417920

[9] Nakra NA,Herrera-Guerra A.Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management.Children (Basel)2020;7:E69 PMCID:PMC7401880

[10] Loke YH,Harahsheh AS.Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease?.Trends Cardiovasc Med2020;30:389-96 PMCID:PMC7370900

[11] Picichè M.Editoral commentary: cardiac involvement in SARS-CoV-2-associated inflammatory syndromes.Trends Cardiovasc Med2020;30:397-8 PMCID:PMC7403028

[12] Feldstein LR,Friedman KG.Overcoming COVID-19 InvestigatorsCharacteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.JAMA2021;325:1074-87 PMCID:PMC7905703

[13] Valverde I,Sanchez-de-Toledo J.AEPC COVID-19 Rapid Response Team*Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe.Circulation2021;143:21-32

[14] Kaushik S,Derespina KR.Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City.J Pediatr2020;224:24-9 PMCID:PMC7293760

[15] Belhadjer Z,Bajolle F.Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic.Circulation2020;142:429-36

[16] Matsubara D,Wang Y.Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States.J Am Coll Cardiol2020;76:1947-61 PMCID:PMC7467656

[17] Kobayashi R,Ferraro A.Detailed assessment of left ventricular function in multisystem inflammatory syndrome in children, using strain analysis.CJC Open2021;3:880-7 PMCID:PMC7905387

[18] Alsaied T,Burns JC.Review of cardiac involvement in multisystem inflammatory syndrome in children.Circulation2021;143:78-88

[19] Raymond TT,Manzuri S,Guleserian K.Pediatric COVID-19 and pericarditis presenting with acute pericardial tamponade.World J Pediatr Congenit Heart Surg2020;11:802-4 PMCID:PMC7484599

[20] Whittaker E,Kenny J.PIMS-TS Study Group and EUCLIDS and PERFORM ConsortiaClinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.JAMA2020;324:259-69 PMCID:PMC7281356

[21] Feldstein LR,Horwitz SM.Overcoming COVID-19 Investigators, CDC COVID-19 Response TeamMultisystem inflammatory syndrome in U.S. children and adolescents.N Engl J Med2020;383:334-46 PMCID:PMC7346765

[22] Haghighi Aski B,Abolhasan Choobdar F,Sakhaei M.Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: a systematic review and meta-analysis.Int J Cardiol Heart Vasc2021;33:100764 PMCID:PMC7983575

[23] Ramcharan T,Lai CY.Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK Tertiary Paediatric Hospital.Pediatr Cardiol2020;41:1391-401 PMCID:PMC7289638

[24] Choi NH,Starc T.MIS-C and cardiac conduction abnormalities.Pediatrics2020;146:e2020009738

[25] Regan W,Stewart K.Electrocardiographic changes in children with multisystem inflammation associated with COVID-19: associated with coronavirus disease 2019.J Pediatr2021;234:27-32.e2 PMCID:PMC7836928

[26] Domico M,Hunt JL,Nugent D.High-grade heart block requiring transvenous pacing associated with multisystem inflammatory syndrome in children during the COVID-19 pandemic.HeartRhythm Case Rep2020;6:811-4 PMCID:PMC7446646

[27] Jonat B,Boneparth A.Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a Children's Hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up.Pediatr Crit Care Med2021;22:e178-91 PMCID:PMC7924927

[28] Elias MD,Larios G.of the International Kawasaki Disease RegistryManagement of multisystem inflammatory syndrome in children associated with COVID-19: a survey from the international Kawasaki disease registry.CJC Open2020;2:632-40 PMCID:PMC7484693

[29] Abdel-Haq N,Deza Leon MP.SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.Eur J Pediatr2021;180:1581-91 PMCID:PMC7810600

[30] Son MBF,Friedman K.Overcoming COVID-19 InvestigatorsMultisystem inflammatory syndrome in children - initial therapy and outcomes.N Engl J Med2021;385:23-34 PMCID:PMC8220972

[31] McArdle AJ,Patel H.BATS ConsortiumTreatment of multisystem inflammatory syndrome in children.N Engl J Med2021;385:11-22 PMCID:PMC8220965

[32] Penner J,Grant K.GOSH PIMS-TS MDT Group6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study.Lancet Child Adolesc Health2021;5:473-82